# The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive

> **NCT02677207** · PHASE2 · COMPLETED · sponsor: **Tangent Data** · enrollment: 80 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** JNJ-39393406
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02677207
- **Lead sponsor:** Tangent Data
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677207, "The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02677207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*